Yosef Kalish

1.3k total citations
70 papers, 803 citations indexed

About

Yosef Kalish is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yosef Kalish has authored 70 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Internal Medicine, 21 papers in Hematology and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yosef Kalish's work include Venous Thromboembolism Diagnosis and Management (23 papers), Atrial Fibrillation Management and Outcomes (14 papers) and Blood Coagulation and Thrombosis Mechanisms (12 papers). Yosef Kalish is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (23 papers), Atrial Fibrillation Management and Outcomes (14 papers) and Blood Coagulation and Thrombosis Mechanisms (12 papers). Yosef Kalish collaborates with scholars based in Israel, United States and United Kingdom. Yosef Kalish's co-authors include Amihai Rottenstreich, Geffen Kleinstern, Bruria Hirsh Raccah, Galia Spectre, Eyal Fenig, Moshe Mishaeli, Michael Lishner, Nael Da’as, Ram Elazary and Amichai Perlman and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yosef Kalish

61 papers receiving 781 citations

Peers

Countries citing papers authored by Yosef Kalish

Since Specialization

Citations

This map shows the geographic impact of Yosef Kalish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yosef Kalish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yosef Kalish more than expected).

Fields of papers citing papers by Yosef Kalish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yosef Kalish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yosef Kalish. The network helps show where Yosef Kalish may publish in the future.

Co-authorship network of co-authors of Yosef Kalish

This figure shows the co-authorship network connecting the top 25 collaborators of Yosef Kalish. A scholar is included among the top collaborators of Yosef Kalish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yosef Kalish. Yosef Kalish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Establishing the Principles for Antithrombogenic Coatings Based on Sol–Gel Films 2025 ·Langmuir ·(unknown), Ela Shai, Yosef Kalish, Meital Reches, Daniel Mandler	0
2	Von Willebrand factor and JAK2V617F variant allele frequency predict thrombosis and bleeding in patients with myeloproliferative neoplasms 2025 ·Annals of Hematology ·Andrea Gat, (unknown), (unknown), Ela Shai, (unknown), (unknown), Yosef Kalish, Ariela Arad, Eran Zimran	0
3	High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T) 2025 ·Cancers ·Ariela Arad, Maya Katz, (unknown), Yosef Kalish, Miri Assayag, Batia Avni, Shlomo Elias, Sigal Grisariu, Ela Shai, Shlomit Kfir‐Erenfeld, (unknown), Moshe E. Gatt, Polina Stepensky, Eran Zimran	0
4	The level is in the details: Why differences between direct‐acting oral anticoagulants should be considered in the treatment of patients with epilepsy 2024 ·Epilepsia ·(unknown), (unknown), Bruria Hirsh Raccah, Ilan Matok, Dana Ekstein, Lee H. Goldstein, Yosef Kalish, Eyal Ert	0
5	Clopidogrel underactivity is a common in patients with acute symptomatic severe carotid stenosis 2021 ·Journal of the Neurological Sciences ·Asaf Honig, (unknown), (unknown), (unknown), Yosef Kalish, John M. Gomori, Anat Horev, Ronen R. Leker, José E. Cohen	3
6	Pregnancy and non-pregnancy related immune thrombotic thrombocytopenic purpura in women of reproductive age 2020 ·Journal of Thrombosis and Thrombolysis ·Amihai Rottenstreich, (unknown), (unknown), Galit Sarig, Yona Nadir, Martin Ellis, Galia Spectre, Ilya Kirgner, (unknown), Ariela Arad, Eldad J. Dann, Yosef Kalish	4
7	[RISK FACTORS ASSOCIATED WITH THE DEVELOPMENT OF UPPER EXTREMITY DEEP VEIN THROMBOSIS FOLLOWING PERIPHERALLY INSERTED CENTRAL CATHETER INSERTION]. 2019 ·PubMed ·(unknown), Amihai Rottenstreich, Yosef Kalish	1
8	Factors associated with pregnancy outcomes in women with a history of cerebral sinus venous thrombosis 2019 ·Journal of Thrombosis and Thrombolysis ·Amihai Rottenstreich, (unknown), Galia Spectre, Nael Da’as, Ohad S. Bentur, Gabriel Levin, Yosef Kalish	4
9	Management strategies of the interaction between direct oral anticoagulant and drug-metabolizing enzyme inducers 2019 ·Journal of Thrombosis and Thrombolysis ·Amichai Perlman, (unknown), (unknown), (unknown), Bruria Hirsh Raccah, (unknown), (unknown), (unknown), Ilan Matok, Laurent Azoulay, Yosef Kalish, Mordechai Muszkat	17
10	Direct-acting oral anticoagulant drug level monitoring in clinical patient management 2018 ·Journal of Thrombosis and Thrombolysis ·Amihai Rottenstreich, (unknown), Geffen Kleinstern, Bruria Hirsh Raccah, (unknown), Nael Da’as, Yosef Kalish	32
11	Antiphospholipid antibody profile-based outcome of purely vascular and purely obstetric antiphospholipid syndrome 2018 ·Journal of Thrombosis and Thrombolysis ·Amihai Rottenstreich, Ariela Arad, (unknown), Uriel Elchalal, (unknown), (unknown), Yosef Kalish	6
12	Drug interaction as a predictor of direct oral anticoagulant drug levels in atrial fibrillation patients 2018 ·Journal of Thrombosis and Thrombolysis ·Bruria Hirsh Raccah, Amihai Rottenstreich, (unknown), Mordechai Muszkat, Ilan Matok, Amichai Perlman, Yosef Kalish	20
13	Assessment of the procoagulant potential after laparoscopic sleeve gastrectomy: a potential role for extended thromboprophylaxis 2017 ·Surgery for Obesity and Related Diseases ·Amihai Rottenstreich, Ram Elazary, Jonathan B. Yuval, Galia Spectre, Geffen Kleinstern, Yosef Kalish	10
14	Abdominal thrombotic complications following bariatric surgery 2016 ·Surgery for Obesity and Related Diseases ·Amihai Rottenstreich, Ram Elazary, Yosef Kalish	37
15	Active malignancy in patients with renal vein thrombosis: influence upon clinical course and survival 2016 ·Clinical and Experimental Nephrology ·Amihai Rottenstreich, (unknown), Nael Da’as, Geffen Kleinstern, David Varon, Yosef Kalish	6
16	Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera 2016 ·European Journal of Internal Medicine ·Amihai Rottenstreich, Geffen Kleinstern, Svetlana Krichevsky, D. Varon, David Lavie, Yosef Kalish	49
17	Pregnancy and non-pregnancy related ovarian vein thrombosis: Clinical course and outcome 2016 ·Thrombosis Research ·Amihai Rottenstreich, Nael Da’as, Geffen Kleinstern, Galia Spectre, Hagai Amsalem, Yosef Kalish	38
18	Endovascular infection following inferior vena cava (IVC) filter insertion 2015 ·Journal of Thrombosis and Thrombolysis ·Amihai Rottenstreich, Rachel Bar‐Shalom, Allan I. Bloom, Yosef Kalish	7
19	Late cytomegalovirus infection occurring two or more years following liver transplantation: a report of seven cases and review of the literature 2003 ·Transplantation Proceedings ·Oren Shibolet, Yaron Ilan, Yosef Kalish, Rifaat Safadi, Yaffa Ashur, Ahmed Eid, Daniel Shouval, Dana G. Wolf	4
20	Late cytomegalovirus disease following liver transplantation 2002 ·Transplant International ·Oren Shibolet, Yaron Ilan, Yosef Kalish, Rifaat Safadi, Yaffa Ashur, Ahmed Eid, Daniel Shouval, Dana G. Wolf	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact